Fig. 7
From: Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
The role of ZDHHC16 in TIME features. a Comparison of stromal score, immune score and ESTIMATE score between low-/high-ZDHHC16 groups. b Comparison of tumor purity between low-/high-ZDHHC16 groups. c Copy number of immune cells in HCC. d Relationship between risk score with B cells, CD8 T cells, CD4 T cells, Macrophages, Neutrophils and Dendritic cells. e Comparison of ssGSEA enrichment between low-/high-ZDHHC16 groups. f Comparison of CIBERSORT results between low-/high-ZDHHC16 groups